Company TiumBio Co., Ltd.

Equities

A321550

KR7321550006

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per region

Sector Bio Therapeutic Drugs

End-of-day quote Korea S.E. Other stock markets 03:30:00 31/05/2024 am IST			5-day change	1st Jan Change
6,770 ^KRW	+2.73%		-4.38%	-30.71%

01/06	Tiumbio Co., Ltd. Presents Phase 1B Interim Results for Tu2218 in Combination with Pembrolizumab At Asco 2024 Annual Meeting	CI
08/05	TiumBio Co., Ltd. Announces Positive Topline Data from Phase 2A Trial of Merigolix in Patients with Moderate to Severe Endometriosis-Associated Pain	CI

TiumBio Co., Ltd. is a Korea-based company principally engaged in the research and development of biopharmaceuticals. The Company researches and develops small molecule drugs including endometriosis treatments, uterine fibroids treatments, cancer immunotherapy drugs; and new biopharmaceuticals including hemophilia treatments, and others.

KRW in Million	2022	Weight	2023	Weight	Delta
Therapeutic Drugs 100.0 %	9,118	100.0 %	4,899	100.0 %	-46.27%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 100.0 %	1,104	12.1 %	4,899	100.0 %	+343.68%

Managers	Title	Age	Since
Hoon-Taek Kim CEO	Chief Executive Officer	58	-
Hyun-Sil Go DFI	Director of Finance/CFO	45	-
In-Young Song BRD	Director/Board Member	51	-
Jong-Yoon Lee AUD	Comptroller/Controller/Auditor	56	-

Members of the board	Title	Age	Since
Mahn-Soon Hwang BRD	Director/Board Member	54	-
Hoon-Taek Kim CEO	Chief Executive Officer	58	-
In-Young Song BRD	Director/Board Member	51	-
Hyun-Sil Go DFI	Director of Finance/CFO	45	-
Jae-Sang Kim BRD	Director/Board Member	60	01/18/01
Dong-Pil Gang BRD	Director/Board Member	60	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	25,982,493	15,102,808 ( 58.13 %)	0	58.13 %
Stock B	0	2,816,053	0	0

Name	Equities	%	Valuation
Hoon-Taek Kim 31.42 %	8,125,766	31.42 %	43 M ₩
Korea Investment Partners Co., Ltd. 10.93 %	2,826,650	10.93 %	15 M ₩
SK CHEMICALS CO.,LTD 8.971 %	2,320,185	8.971 %	12 M ₩
In-Young Song 0.5955 %	154,000	0.5955 %	821 200 ₩
Hyun-Sil Go 0.5413 %	140,000	0.5413 %	746 546 ₩
Sun-mi Kim 0.4041 %	104,500	0.4041 %	557 243 ₩
Jae-hee Han 0.2707 %	70,000	0.2707 %	373 273 ₩
Jin-woo Jung 0.2707 %	70,000	0.2707 %	373 273 ₩
Sung-eun Kim 0.1160 %	30,000	0.1160 %	159 974 ₩
Jae Eun Jeon 0.005529 %	1,430	0.005529 %	7 625 ₩

TiumBio Co., Ltd.

4/F, Dasan Tower 49 Daewangpangyo-ro 644beon-gil

13493, Seongnam

http://www.tiumbio.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Therapeutic Drugs

	1st Jan change	Capi.
TIUMBIO CO., LTD.	-30.71%	13Cr
REGENERON PHARMACEUTICALS, INC.	+11.60%	11TCr
BIONTECH SE	-4.68%	2.43TCr
ARGENX SE	-0.82%	2.2TCr
GENMAB A/S	-10.12%	1.82TCr
WUXI APPTEC CO., LTD.	-42.12%	1.64TCr
BEIGENE, LTD.	-17.47%	1.56TCr
NEUROCRINE BIOSCIENCES, INC.	+2.77%	1.36TCr
SAREPTA THERAPEUTICS, INC.	+34.58%	1.23TCr
INSMED INCORPORATED	+77.64%	887.31Cr

Bio Therapeutic Drugs